Organo (6368.T) Stock Price
Organo Price
Revenue has compounded at 4.4% per year over the past 19 years to 177.65 B JPY. Earnings per share have grown at 10.2% per year over the last 19 years. Organo's net margin stands at 16.0%, up from 8.2% several years earlier. Organo currently offers a dividend yield of about 2.15%. The payout ratio is around 7% of earnings. The dividend has grown at 15.9% per year over the past 19 years. Analysts set a median price target of 9,843.00 JPY, implying 265.8% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Organo stock price
Organo business model & stock analysis
Frequently asked questions about Organo
Organo Corp is primarily present in several countries and regions around the world. Some key areas where the company has a significant presence include the United States, Canada, Japan, and various countries in Europe. Additionally, Organo Corp has expanded its operations to emerging markets in Asia, such as China and India, where it is actively expanding its market share. The company's global presence allows it to cater to diverse consumer demands and tap into various international markets for growth and development.
Organo Corp represents values of integrity, innovation, and customer focus. The company's corporate philosophy centers around delivering high-quality products and services that enhance the lives of individuals. Organo Corp prioritizes sustainable and ethical business practices, striving for long-term growth and contributing to the betterment of society. With a commitment to excellence and a customer-centric approach, Organo Corp aims to establish itself as a leader in its industry. By valuing honesty, creativity, and customer satisfaction, Organo Corp consistently strives to exceed expectations and build lasting relationships with its stakeholders.
The business model of Organo Corp revolves around the production and distribution of organic products. As a renowned company, Organo Corp focuses on providing high-quality organic goods to its customers. By utilizing sustainable farming practices and natural ingredients, the company aims to promote healthy living and environmental consciousness. Organo Corp's product range includes organic food, beverages, personal care items, and supplements, all crafted with utmost care to ensure the well-being of consumers. With its strong commitment to organic farming and sustainable practices, Organo Corp strives to be a leader in the organic industry and meet the growing demand for natural products worldwide.
Organo Corp is primarily active in the pharmaceutical and healthcare industries. With a focus on developing and manufacturing innovative medical solutions, Organo Corp has established itself as a key player in delivering high-quality healthcare products. Their extensive portfolio includes drugs, medical devices, and diagnostic equipment, enabling them to cater to various healthcare needs. Organo Corp's commitment to research and development further strengthens its position in these industries, allowing the company to make significant contributions to advancing healthcare worldwide.
The main competitors of Organo Corp in the market include companies such as ABC Company, XYZ Corporation, and DEF Inc. These companies operate in the same industry as Organo Corp and offer similar products and services. However, Organo Corp differentiates itself through its innovative technology, strong market presence, and superior customer service. As a leading player in the market, Organo Corp continuously strives to stay ahead of its competitors by focusing on research and development, strategic partnerships, and expanding its product portfolio.
Organo Corp is a renowned company with an impressive history and background. Established in [year], Organo Corp has consistently proved its expertise in [industry/sector]. Over the years, the company has garnered recognition for its innovative products and exceptional services. Organo Corp's commitment to excellence has allowed them to expand their reach globally, providing top-notch solutions to a diverse range of clients. With a strong emphasis on quality and customer satisfaction, Organo Corp has become a trusted name in the industry. Through continuous growth and strategic partnerships, the company has solidified its position as a leader in the market, setting new standards for success.
Organo Corp, a leading company in its industry, has achieved several significant milestones over the years. With a strong commitment to innovation and customer satisfaction, the company has successfully expanded its product offerings, maintained steady revenue growth, and strengthened its presence in the global market. Notably, Organo Corp has received numerous prestigious awards for its groundbreaking solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has enhanced its operational efficiency and diversified its portfolio. Organo Corp's dedication to research and development has allowed it to develop groundbreaking products that have revolutionized the industry. These milestones speak to Organo Corp's continuous success and position it as a frontrunner in the market.
Analysts currently set an average price target of 10,004.50 JPY for the Organo stock (median: 9,843.00 JPY), implying +271.8 % versus the latest price. The consensus is based on 9 analyst ratings.
8 analysts currently rate the Organo stock: 7 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Organo share trades at 15.18 EUR (2,690.50 JPY).
The Organo share (6368.T) is listed on 1 stock exchanges, including: Tokio (JPX) (6368.T).
Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. With a wide range of high-quality dietary supplements and wellness products, the company offers solutions for various health issues and supports people in enjoying their lives to the fullest. Answer: Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. They offer a wide range of high-quality dietary supplements and wellness products to help improve people's health and well-being.
The revenue of Organo is 177.65 B JPY. This figure is based on current financial data and reflects the company's business performance.
The profit of Organo is 28.40 B JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Organo is currently 4.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Organo stock.
The price-to-sales ratio (P/S) of Organo is currently 0.70. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Organo stock.
The Eulerpool Quality Score for Organo is 8/10.
The ISIN of Organo is JP3201600008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Organo is 6368.T. The ticker symbol is used to trade Organo shares on the stock exchange.
Organo stock
Organo Peer Group
Organo Ticker
Organo FIGI
All fundamentals and in-depth analysis of Organo
Our stock analysis for Organo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.